K+ channel expression during B cell differentiation: Implications for immunomodulation and autoimmunity

Journal of Immunology

Volumn 173, Issue 2, 2004, Pages 776-786

  Wulff, Heike ^a,e   Knaus, Hans Günther ^b   Pennington, Michael ^c   Chandy, K George ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c Bachem Holding AG   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CD27 ANTIGEN; IMMUNOGLOBULIN D; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; STICHODACTYLA HELIANTHUS TOXIN; TOXIN; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CALCIUM CONDUCTANCE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MEMORY CELL; MITOGENESIS; NORMAL HUMAN; PATCH CLAMP; PHENOTYPE; POTASSIUM CONDUCTANCE; POTASSIUM CURRENT; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 3142775617     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.2.776     Document Type: Article

References (86)

1. Gutman, G. A., K. G. Chandy, J. P. Adelman, J. Aiyar, D. A. Bayliss, D. E. Clapham, M. Covarriubias, G. V. Desir, K. Furuichi, B. Ganetzky, et al. 2003. International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels. Pharmacol. Rev. 55:583.
2. + channels in human T lymphocytes: a role in mitogenesis? Nature 307:465.
3. Chandy, K. G., T. E. DeCoursey, M. D. Cahalan, C. McLaughlin, and S. Gupta. 1984. Voltage-gated potassium channels are required for human T lymphocyte activation. J. Exp. Med. 160:369.
4. Lin, C. S., R. C. Boltz, J. T. Blake, M. Nguyen, A. Talento, P. A. Fischer, M. S. Springer, N. H. Sigal, R. S. Slaughter, M. L. Garcia, et al. 1993. Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J. Exp. Med. 177:637.
5. Koo, G. C., J. T. Blake, A. Talento, M. Nguyen, S. Lin, A. Sirotina, K. Shah, K. Mulvany, D. Hora, Jr., P. Cunningham, et al. 1997. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J. Immunol. 158:5120.
6. Wulff, H., C. Beeton, and K. G. Chandy. 2003. Potassium channels as therapeutic targets for autoimmune disorders. Curr. Opin. Drug Discov. Devel. 6:640.
7. Chandy, K. G., H. Wulff, C. Beeton, M. Pennington, G. A. Gutman, and M. D. Cahalan. Potassium channels as targets for specific immunomodulation. Trends Pharmacol. Sci. In press.
8. 2+ stores. Proc. Natl. Acad. Sci. USA 90:6295.
9. Lewis, R. S., and M. D. Cahalan. 1995. Potassium and calcium channels in lymphocytes. Annu. Rev. Immunol, 13:623.
10. Cahalan, M. D., H. Wulff, and K. G. Chandy. 2001. Molecular properties and physiological roles of ion channels in the immune system. J. Clin. Immunol. 21:235.
11. Lewis, R. S. 2001. Calcium signaling mechanisms in T lymphocytes. Annu. Rev. Immunol. 19:497.
12. Hess, S. D., M. Oortgiesen, and M. D. Cahalan. 1993. Calcium oscillations in human T and natural killer cells depend upon membrane potential and calcium influx. J. Immunol. 150:2620.
13. Fanger, C. M., H. Rauer, A. L. Neben, M. J. Miller, H. Rauer, H. Wulff, J. C. Rosa, C. R. Ganellin, K. G. Chandy, and M. D. Cahalan. 2001. Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. J. Biol. Chem. 276:12249.
14. Ghanshani, S., H. Wulff, M. J. Miller, H. Rohm, A. Neben, G. A. Gutman, M. D. Cahalan, and K. G. Chandy. 2000. Up-regulation of the IKCa1 potassium channel during T-cell activation: molecular mechanism and functional consequences. J. Biol. Chem. 275:37137.
15. + channel in effector memory T cells as new target for MS. J. Clin. Invest. 111:1703.
16. + channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl. Acad. Sci. USA 98:13942.
17. O'Connor, K. C., A. Bar-Or, and D. A. Hafler. 2001. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J. Clin. Immunol. 21:81.
18. Iglesias, A., J. Bauer, T. Litzenburger, A. Schubart, and C. Linington. 2001. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36:220.
19. Berger, T., P. Rubner, F. Schautzer, R. Egg, H. Ulmer, I. Mayringer, E. Dilitz, F. Deisenhammer, and M. Reindl. 2003. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N. Engl. J. Med. 349:139.
20. + peripheral blood B cells expressing CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1679.
21. Agematsu, K., S. Hokibara, H. Nagumo, and A. Komiyama. 2000. CD27: a memory B-cell marker. Immunol. Today 21:204.
22. + B cells are crucial in secondary immune response by producing high affinity IgM. Clin. Immunol. 108:128.
23. Atkinson, M. A., and G. S. Eisenbarth. 2001. Type I diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221.
24. Domer, T., and G. R. Burmester. 2003. The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets. Curr. Opin. Rheumatol. 15:246.
25. Sutro, J. B., B. S. Vayuvegula, S. Gupta, and M. D. Cahalan. 1989. Voltage-sensitive ion channels in human B lymphocytes. Adv. Exp. Med. Biol. 254:113.
26. + channels. J. Immunol. 144:2038.
27. Brent, L. H., J. L. Butler, W. T. Woods, and J. K. Bubien. 1990. Transmembrane ion conductance in human B lymphocyte activation. J. Immunol. 145:2381.
28. Partiseti, M., D. Choquet, A. Diu, and H. Korn. 1992. Differential regulation of voltage- and calcium-activated potassium channels in human B lymphocytes. J. Immunol. 148:3361.
29. Partiseti, M., H. Korn, and D. Choquet. 1993. Pattern of potassium channel expression in proliferating B lymphocytes depends upon the mode of activation. J. Immunol. 151:2462.
30. + channel, IKCa1: a potential immunosuppressant. Proc. Natl. Acad. Sci. USA 97:8151.
31. Vennekamp, J., H. Wulff, C. Beeton, P. A. Calabresi, S. Grissmer, W. Hänsel, and K. G. Chandy. 2004. Kv1.3 blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol. Pharmacol. 65:1364.
32. Bondada, S., and D. A. Robertson. 2003. Assays for B cell function. In Current Protocols in Immunology, Vol. I. J. E. Coligan, A. M. Kruisbeek, D. Margulies, E. M. Shevach, and W. Strober, eds. Wiley, New York, p. 3.8.1.S. W.
33. Pound, J. D., A. Challa, M. J. Holder, R. J. Armitage, S. K. Dower, W. C. Fanslow, H. Kikutani, S. Paulie, C. D. Gregory, and J. Gordon. 1999. Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells. Int. Immunol. 11:11.
34. Thomas, A. K., M. V. Maus, W. S. Shalaby, C. H. June, and J. L. Riley. 2002. A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes. Clin. Immunol. 105:259.
35. + channel gene. Proc. Natl. Acad. Sci. USA 87:9411.
36. + channels: basis for high-affinity toxin interactions and pharmacology. J. Biol. Chem. 272:27577.
37. Beeton, C., H. Wulff, S. Singh, S. Bosko, G. Crossley, G. A. Gutman, M. D. Cahalan, M. Pennington, and K. G. Chandy. 2003. A novel fluorescent toxin to detect and investigate Kv1.3-channel up-regulation in chronically, activated T lymphocytes. J. Biol. Chem. 278:9928.
38. Lewis, R. S., and M. D. Cahalan. 1988. Subset-specific expression of potassium channels in developing murine T lymphocytes. Science 239:771.
39. Decoursey, T. E., K. G. Chandy, S. Gupta, and M. D. Cahalan. 1987. Two types of potassium channels in murine T lymphocytes. J. Gen. Physiol. 89:379.
40. + lymphocyte differentiation. J. Exp. Med. 196:897.
41. Bar-Or, A., E. M. Oliveira, D. E. Anderson, J. I. Krieger, M. Duddy, K. C. O'Connor, and D. A. Hafler. 2001. Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state. J. Immunol. 167:5669.
42. Sellebjerg, F., J. Jensen, and L. P. Ryder. 1998. Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis. J. Neuroimmunol. 84:179.
43. + B cells in active multiple sclerosis and reversal by interferon-β-1b therapy. J. Clin. Invest. 99:2664.
44. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
45. Girvin, A. M., M. C. Dal Canto, L. Rhee, B. Salomon, A. Sharpe, J. A. Bluestone, and S. D. Miller. 2000. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J. Immunol. 164:136.
46. Burstein, H. J., and A. K. Abbas. 1991. T-cell-mediated activation of B cells. Curr. Opin. Immunol. 3:345.
47. Morente, M., J. L. Piris, C. Orradre, R. Rivas, and R. Villuendas. 1992. Human tonsil intraepithelial B cells: a marginal zone-related subpopulation. J. Clin. Pathol. 45:668.
48. Dono, M., S. Zupo, N. Leanza, G. Melioli, M. Fogli, A. Melagrana, N. Chiorazzi, and M. Ferrarini. 2000. Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J. Immunol. 164:5596.
49. Tangye, S. G., Y. J. Liu, G. Aversa, J. H. Phillips, and J. E. de Vries. 1998. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188:1691.
50. Zandvoort, A., M. E. Lodewijk, N. K. de Boer, P. M. Darnmers, F. G. Kroese, and W. Timers. 2001. CD27 expression in the human splenic marginal zone: the infant marginal zone is populated by naive B cells. Tissue Antigens 58:234.
51. DeBenedette, M., J. W. Olson, and E. C. Snow. 1993. Expression of polyamine transporter activity during B lymphocyte cell cycle progression. J. Immunol. 150:4218.
52. Dearden-Badet, M. T., and J. P. Revillard. 1993. Requirement for tyrosine phosphorylation in lipopolysaccharide-induced murine B-cell proliferation. Immunology 80:658.
53. Franklin, R. A., A. Tordai, B. Mazer, N. Terada, J. J. Lucas, and E. W. Gelfand. 1994. Activation of MAP2-kinase in B lymphocytes by calcium ionophores. J. Immunol. 153:4890.
54. Verkoczy, L. K., B. J. Stiernhdm, and N. L. Berinstein. 1995. Up-regulation of recombination activating gene expression by signal transduction through the surface Ig receptor. J. Immunol. 154:5136.
55. Son, N. H., S. Murray, J. Yanovski, R. J. Hodes, and N. Weng. 2000. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J. Immunol. 165:1191.
56. Irigoyen, M., T. Mizuno, X. Zhong, R. S. Negm, T. J. Schneider, and T. L. Rothstein. 2002. B cell activation leads to upregulated expression of the murine Sik-similar protein gene. Mol. Immunol. 38:861.
57. Dolmetsch, R. E., K. Xu, and R. S. Lewis. 1998. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392:933.
58. Feske, S., J. Giltnane, R. Dolmetsch, L. M. Staudt, and A. Rao. 2001. Gene regulation mediated by calcium signals in T lymphocytes. Nat. Immunol. 2:316.
59. 2+ signaling. Cell Calcium 17:287.
60. + channel block by charybdotoxin depend on the T cell activation state. Cell Calcium 21:1.
61. 1 integrins. J. Exp. Med. 191:1167.
62. Panyi, G., M. Bagdany, A. Bodnar, G. Vamosi, G. Szentesi, A. Jenei, L. Matyus. S. Varga, T. A. Waldmann, R. Gaspar, and S. Damjanovich. 2003. Colocalization and nonrandom distribution of the Kv1.3 potassium channel and CD3 molecules in the plasma membrane of human T lymphocytes. Proc. Natl. Acad. Sci. USA 100:2592.
63. Panyi, G., G. Vamosi, Z. Bacso, M. Bagdany, A. Bodnar, Z. Varga, R. Gaspar, L. Matyus, and S. Damjanovich. 2004. Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells. Proc. Natl. Acad. Sci. USA 101:1285.
64. Wojtulewski, J. A., P. J. Gow, J. Walter, R. Grahame, T. Gibson, G. S. Panayi, and J. Mason. 1980. Clotrimazole in rheumatoid arthritis. Ann. Rheum. Dis. 39:469.
65. Panayi, G. S. 1995. Treating rheumatoid arthritis with clotrimazole. Nat. Med. 1:977.
66. Köhler, R., H. Wulff, I. Eichler, M. Kneifel, D. Neumann, A. Knorr, I. Grgic, D. Kampfe, H. Si, J. Wibawa, et al. 2003. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 108:1119.
67. Stocker, J. W., L. De Franceschi, G. A. McNaughton-Smith, R. Corrocher, Y. Beuzard, and C. Brugnara. 2003. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood 101:2412.
68. Ca channel blockers. Bioorg. Med. Chem. Lett. 13:2637.
69. Koo, G. C., J. T. Blake, K. Shah, M. J. Staruch, F. Dumont, D. Wunderler, M. Sanchez, O. B. McManus, A. Sirotina-Meisher, P. Fischer, et al. 1999. Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels. Cell. Immunol. 197:99.
70. + channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J. Immunol. 166:936.
71. Cahalan, M. D., and K. G. Chandy. 1997. Ion channels in the immune system as targets for immunosuppression. Curr. Opin. Biotechnol 8:749.
72. Soler, D., T. L. Humphreys, S. M. Spinola, and J. J. Campbell. 2003. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood 101:1677.
73. Chong, B. F., J. E. Murphy, T. S. Kupper, and R. C. Fuhlbrigge. 2004. E-selectin, thymus- and activation-regulated chemokine/CCL17, and intercellular adhesion molecule-1 are constitutively coexpressed in dermal microvessels: a foundation for a cutaneous immunosurveillance system. J. Immunol. 172:1575.
74. Lovett-Racke, A. E., J. L. Trotter, J. Lauber, P. J. Perrin, C. H. June, and M. K. Racke. 1998. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients: a marker of activated/memory T cells. J. Clin. Invest. 101:725.
75. Friedrich, M., S. Krammig, M. Henze, W. D. Docke, W. Sterry, and K. Asadullah. 2000. Flow cytometric characterization of lesional T cells in psoriasis: intracellular cytokine and surface antigen expression indicates an activated, memory effector/type 1 immunophenotype. Arch. Dermatol. Res. 292:519.
76. Yoon, J. W., and H. S. Jun. 2001. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Ann. NY Acad. Sci. 928:200.
77. Viglietta, V., S. C. Kent, T. Orban, and D. A. Hafler. 2002. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J. Clin. Invest. 109:895.
78. Jaume, J. C., S. L. Parry, A. M. Madec, G. Sonderstrup, and S. Baekkeskov. 2002. Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope. J. Immunol. 169:665.
79. Serreze, D. V., S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 15:3912.
80. Serreze, D. V., and P. A. Silveira. 2003. The role of B lymphocytes as key antigen-presenting cells in the development of T-cell mediated autoimmune type-1 diabetes. Curr. Dir. Autoimmun. 6:212.
81. Valverde, P., T. Kawai, and M. A. Taubman. 2004. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. J. Bone Miner. Res. 19:155.
82. Schmalhofer, W. A., J. Bao, O. B. McManus, B. Green, M. Matyskiela, D. Wunderler, R. M. Bugianesi, J. P. Felix, M. Hanner, A.-R. Linde-Arias, et al. 2002. Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant properties. Biochemistry 18:7781.
83. Baell, J. B., R. W. Gable, A. J. Harvey, N. Toovey, T. Herzog, W. Hansel, and H. Wulff. 2004. Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity. J. Med. Chem. 47:2326.
84. Kalman, K., M. W. Pennington, M. D. Lanigan, A. Nguyen, H. Rauer, V. Mahnir, K. Paschetto, W. R. Kem, S. Grissmer, G. A. Gutman, et al. 1998. ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide, J. Biol. Chem. 273:32697.
85. Cahalan, M. D., K. G. Chandy, T. E. DeCoursey, and S. Gupta. 1985. A voltage-gated potassium channel in human T lymphocytes. J. Physiol. (Lond.) 58:197.
86. Grissmer, S., A. N. Nguyen, and M. D. Cahalan. 1993. Calcium-activated potassium channels in resting and activated human T lymphocytes: expression levels, calcium dependence, ion selectivity, and pharmacology. J. Gen. Physiol. 102:601.